North America Travel Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

Code: BMIRE00025499 | Pages: 120 | Industry: Pharmaceuticals | Date: Jul 2022 | Type: Regional

The travel vaccines market in North America is expected to grow from US$ 1,276.32 million in 2021 to US$ 2,503.59 million by 2028; it is estimated to grow at a CAGR of 10.1% from 2021 to 2028.

 

Travelling and tourism have become an integral part of the human lifestyle. Travelling and tourism have not only added a change in the ongoing routine of people but have also offered opportunities to explore different cultures, traditions, spiritualism, rural and ethnic tourism, wellness and health holidays, and many more worldwide. Travelling outside the country requires immunization as a safety and precautionary measure to avoid spreading infections. Various countries have policies to protect their citizens from travel-associated infections. The above estimates suggest that travel and tourism will increase in the coming years. Furthermore, economic crises and demand for better job opportunities contributed to the increasing travel and tourism across the region. Thus, the increasing travel and tourism propel the demand for travel vaccines. Furthermore, economic crises and demand for better job opportunities have contributed to the increasing travel and tourism worldwide. Thus, the increasing travel and tourism propel the demand for travel vaccines.  

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America travel vaccines market. The North America travel vaccines market is expected to grow at a good CAGR during the forecast period.     

 

North America Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

North America Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

 

North America Travel Vaccines Market Segmentation        

 

North America travel vaccines market is segmented into product, application, and country. The North America travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. By application, the North America travel vaccines market is segmented into domestic and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the North America travel vaccines market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2021.   

 

Abbott; Dynavax Technologies; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and Valneva SE are among the leading companies in the travel vaccines market in the region.     

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Travel Vaccines Market – By Product

1.3.2        North America Travel Vaccines Market – By Application

1.3.3        North America Travel Vaccines Market – By Country

2.           North America Travel Vaccines Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Travel Vaccines Market– Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Travel Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Travel and Tourism

5.1.2        Rising Incidences of Infectious Diseases

5.2         Market Restraints

5.2.1        High Cost of Travel Vaccines

5.3         Market Opportunities

5.3.1        Rising Awareness Regarding Vaccines

5.4         Future Trends

5.4.1        Never-ending Demand for Vaccines

5.5         Impact Analysis

6.           Travel Vaccines Market – North America Analysis

6.1         North America Travel Vaccines Marker Revenue Forecast and Analysis

7.           North America Travel Vaccines Market Analysis – By Product

7.1         Overview

7.2         North America Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

7.3         Hepatitis A

7.3.1        Overview

7.3.2        Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Hepatitis B

7.4.1        Overview

7.4.2        Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.5         Meningococcal Vaccines

7.5.1        Overview

7.5.2        Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.           North America Travel Vaccines Market Analysis – By Application

8.1         Overview

8.2         North America Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

8.3         Domestic Travel

8.3.1        Overview

8.3.2        Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Outbound Travel

8.4.1        Overview

8.4.2        Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

9.           North America Travel Vaccines Market – Country Analysis

9.1         North America: Travel Vaccines Market

9.1.1        North America: Travel Vaccines Market, by Country, 2020 & 2028 (%)

9.1.1.1          US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.1          US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.1.2          US: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.1.3          US: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.2          Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.1          Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.2.2          Canada: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.2.3          Canada: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

9.1.1.3          Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.1          Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

9.1.1.3.2          Mexico: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)

9.1.1.3.3          Mexico: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)

10.        Travel Vaccines Market–Industry Landscape

10.1      Overview

10.2      Growth Strategies in the Travel Vaccines Market, (%)

10.3      Organic Developments

10.3.1     Overview

10.4      Inorganic Developments

10.4.1     Overview

11.        Company Profiles

11.1      GlaxoSmithKline plc.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Merck & Co., Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Sanofi

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Novartis AG

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Pfizer Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Dynavax Technologies

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Emergent BioSolutions Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Abbott

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Valneva SE.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             US: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             US: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             Canada: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Canada: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Mexico: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Mexico: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Organic Developments Done by Companies

Table 8.             Inorganic Developments Done by Companies

Table 9.             Glossary of Terms, North America Travel vaccines Market

 

 

LIST OF FIGURES

Figure 1.           North America Travel Vaccines Market Segmentation

Figure 2.           North America Travel Vaccines Market – By Country

Figure 3.           North America Travel Vaccines Market Overview

Figure 4.           North America Outbound Segment Held Largest Share of Travel Vaccines Market by Product

Figure 5.           US to Show Significant Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           North America Travel Vaccines Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Travel Vaccines Market – Revenue Forecast and Analysis – 2021- 2028

Figure 10.        North America Travel Vaccines Market Revenue Share, by Product (2021 and 2028)

Figure 11.        North America Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        North America Travel Vaccines Market Revenue Share, by Application (2021 and 2028)

Figure 16.        North America Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 19.        North America: Travel Vaccines Market, by Country, 2020 & 2028 (%)

Figure 20.        US: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 21.        Canada: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 22.        Mexico: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 23.        Growth Strategies in the Travel Vaccines Market, (%)

  1. Abbott
  2. Dynavax Technologies
  3. Emergent BioSolutions Inc.
  4. GlaxoSmithKline plc
  5. Merck & Co., Inc.
  6. Novartis AG
  7. Pfizer Inc.
  8. Sanofi
  9. Valneva SE.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000